Oritinib

Oritinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T60076-1mg 1 mg

7 - 10 business days*

128.00€
TGM-T60076-5mg 5 mg

7 - 10 business days*

319.00€
TGM-T60076-1mL 1 ml

7 - 10 business days*

371.00€
TGM-T60076-10mg 10 mg

7 - 10 business days*

465.00€
TGM-T60076-25mg 25 mg

7 - 10 business days*

774.00€
TGM-T60076-50mg 50 mg

7 - 10 business days*

1,032.00€
TGM-T60076-100mg 100 mg

7 - 10 business days*

1,412.00€
 
Description: Oritinib (SH-1028) is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and... more
Product information "Oritinib"
Description: Oritinib (SH-1028) is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and 0.89 nM for EGFR (wt), EGFR (L858R), EGFR (L861Q), EGFR (L858R/T790M), EGFR (d746-750), EGFR (d746-750/T790M), respectively. Oritinib can be used in studies about the treatment of non-small cell lung cancer. Target: EGFR. Smiles: COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1c2CCCCn2c2ccccc12. References: Luwei Han, et al. SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Front Pharmacol. 2021 Apr 27,12:665253.
Keywords: SH-1028
Supplier: TargetMol
Supplier-Nr: T60076

Properties

MW: 539.67 D
Formula: C31H37N7O2

Database Information

CAS : 2035089-28-0| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Oritinib"
Write a review
or to review a product.
Viewed